{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:16:50Z","timestamp":1782393410853,"version":"3.54.5"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Inflammatory bowel disease (IBD), as a chronic and recurrent inflammatory bowel diseases with limited therapeutic outcomes, is characterized by immune disorders and intestinal barrier dysfunction. Currently, the most medications used to cure IBD in clinic just temporarily induce and maintain remission with poor response rates and limited outcomes. Therefore, it is urgently necessary to develop an appropriate therapeutic candidate with preferable efficacy and less adverse reaction for curing IBD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Five groups of mice were utilized: control that received saline, DSS group (mice received 2.5% DSS or 4% DSS), KPV group (mice received KPV), FK506 group (mice received FK506) and NPs groups (mice received NPs). The effect of NP on the inflammatory factors of macrophage was evaluated using CCK-8, quantitative polymerase chain reaction (PCR), Elisa and Western blot (WB). Immunofluorescent staining revealed the targeting relationship between NP and Petp-1. Immunohistochemistry staining showed the effect of NP on tight junction proteins. Moreover, in vivo animal experiments confirmed that NPs reduced inflammatory levels in IBD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and Discussion<\/jats:title><jats:p>After administering with NPs, mice with DSS-induced acute or chronic colitis exhibited significant improvement in body weight, colon length, and disease activity index, decreased the level of the factors associated with oxidative stress (MPO, NO and ROS) and the inflammatory cytokines (TNF-\u03b1, IL-1\u03b2 and IL-6), which implied that NPs could ameliorate murine colitis effectively. Furthermore, treating by NPs revealed a notable reduction of the expressions of CD68 and CD3, restoring the expression levels of tight junction proteins (Claudin-5, Occludin-1, and ZO-1) were significantly restored, surpassing those observed in the KPV and FK506 groups. which indicated that NPs can reduce inflammation and enhance epithelial barrier integrity by decreasing the infiltration of macrophages and T-lymphocytes. Collectively, those results demonstrated the effectively therapeutic outcome after using NPs in both acute and chronic colitis, suggesting that the newly co-assembled of NPs can be as a potential therapeutic candidate for colitis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1442876","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T04:36:50Z","timestamp":1723696610000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced ColitiS"],"prefix":"10.3389","volume":"15","author":[{"given":"Daifang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longqi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pijun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fimmu.2019.00459","article-title":"Combined IL-2 immunocomplex and anti-IL-5 mAb treatment expands Foxp3(+) treg cells in the absence of eosinophilia and ameliorates experimental colitis","volume":"10","author":"Abo","year":"2019","journal-title":"Front. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1084\/jem.20100124","article-title":"Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation","volume":"207","author":"Araki","year":"2010","journal-title":"J. Exp. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.1038\/ncomms8802","article-title":"Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes","volume":"6","author":"Asano","year":"2015","journal-title":"Nat. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/labinvest.2013.77","article-title":"PepT1 expressed in immune cells has an important role in promoting the immune response during experimentally induced colitis","volume":"93","author":"Ayyadurai","year":"2013","journal-title":"Lab. Investig."},{"key":"B5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/gutjnl-2012-303329","article-title":"Non-redundant properties of IL-1\u03b1 and IL-1\u03b2 during acute colon inflammation in mice","volume":"63","author":"Bersudsky","year":"2014","journal-title":"Gut"},{"key":"B6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/ajg.2011.386","article-title":"Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements","volume":"107","author":"Bitton","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/labinvest.3700413","article-title":"hPepT1 mediates bacterial tripeptide fMLP uptake in human monocytes","volume":"86","author":"Charrier","year":"2006","journal-title":"Lab. Investig."},{"key":"B9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ebiom.2019.07.031","article-title":"Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia","volume":"46","author":"Clos-Garcia","year":"2019","journal-title":"EBioMedicine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"118530","DOI":"10.1016\/j.carbpol.2021.118530","article-title":"Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: a review","volume":"272","author":"Cui","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"B12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jconrel.2021.04.026","article-title":"Oral delivery of micro\/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: challenges, advances and future perspectives","volume":"334","author":"Dos Santos","year":"2021","journal-title":"J. Control. Release"},{"key":"B13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s10875-009-9345-1","article-title":"Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease","volume":"30","author":"Eastaff-Leung","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/ibd.21681","article-title":"Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation","volume":"18","author":"Garrity-Park","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1158\/0008-5472.CAN-11-4155","article-title":"Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitis","volume":"72","author":"Gerlach","year":"2012","journal-title":"Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/apt.16785","article-title":"Review article: emerging drug therapies in inflammatory bowel disease","volume":"55","author":"Grossberg","year":"2022","journal-title":"Alimentary Pharmacol. and Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"120557","DOI":"10.1016\/j.biomaterials.2020.120557","article-title":"Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy","volume":"268","author":"Huang","year":"2021","journal-title":"Biomaterials"},{"key":"B18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jconrel.2020.10.014","article-title":"Carrier-free nanodrugs for safe and effective cancer treatment","volume":"329","author":"Karaosmanoglu","year":"2021","journal-title":"J. Control Release"},{"key":"B20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.3390\/nano9091246","article-title":"An orally administrated hyaluronan functionalized polymeric hybrid nanoparticle system for colon-specific drug delivery","volume":"9","author":"Kotla","year":"2019","journal-title":"Nanomaterials"},{"key":"B22","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1053\/j.gastro.2021.09.077","article-title":"The future of precision medicine to predict outcomes and control tissue remodeling in inflammatory bowel disease","volume":"162","author":"Lamb","year":"2022","journal-title":"Gastroenterology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e2201425","DOI":"10.1002\/advs.202201425","article-title":"A combination therapy using electrical stimulation and adaptive, conductive hydrogels loaded with self-assembled nanogels incorporating short interfering RNA promotes the repair of diabetic chronic wounds","volume":"9","author":"Lei","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.3390\/nu11061348","article-title":"Glutamine, but not branched-chain amino acids, restores intestinal barrier function during activity-based anorexia","volume":"11","author":"L\u2019huillier","year":"2019","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3389\/fimmu.2017.00669","article-title":"CD169 expressing macrophage, a Key subset in mesenteric lymph nodes promotes mucosal inflammation in dextran sulfate sodium-induced colitis","volume":"8","author":"Li","year":"2017","journal-title":"Front. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1039\/c5fo00563a","article-title":"Oat \u03b2-glucan ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice","volume":"6","author":"Liu","year":"2015","journal-title":"Food Funct."},{"key":"B28","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s10571-016-0422-8","article-title":"FK506 attenuates the inflammation in rat spinal cord injury by inhibiting the activation of NF-\u03baB in microglia cells","volume":"37","author":"Liu","year":"2017","journal-title":"Cell Mol. Neurobiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.7150\/thno.43716","article-title":"Parthenolide ameliorates colon inflammation through regulating Treg\/Th17 balance in a gut microbiota-dependent manner","volume":"10","author":"Liu","year":"","journal-title":"Theranostics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"108275","DOI":"10.1016\/j.celrep.2020.108275","article-title":"TNF receptor 1 promotes early-life immunity and protects against colitis in mice","volume":"33","author":"Liu","year":"","journal-title":"Cell Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.suc.2015.07.006","article-title":"Inflammatory bowel disease: historical perspective, epidemiology, and risk factors","volume":"95","author":"Malik","year":"2015","journal-title":"Surg. Clin. North Am."},{"key":"B32","doi-asserted-by":"publisher","first-page":"Doc03","DOI":"10.3205\/000126","article-title":"Biomarkers in the management of ulcerative colitis: a brief review","volume":"9","author":"Masoodi","year":"2011","journal-title":"Ger. Med. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/microorganisms7080262","article-title":"Large plasmid complement resolved: complete genome sequencing of lactobacillus plantarum MF1298, a candidate probiotic strain associated with unfavorable effect","volume":"7","author":"Mcleod","year":"2019","journal-title":"Microorganisms"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1053\/gast.2001.24845","article-title":"Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules","volume":"120","author":"Merlin","year":"2001","journal-title":"Gastroenterology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"103017","DOI":"10.1016\/j.autrev.2021.103017","article-title":"The influence of cytokines on the complex pathology of ulcerative colitis","volume":"21","author":"Nakase","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1136\/gut.2005.081794","article-title":"A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis","volume":"55","author":"Ogata","year":"2006","journal-title":"Gut"},{"key":"B37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1615\/critreveukargeneexpr.v20.i2.10","article-title":"Tumor necrosis factor-\u03b1 signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1365-2036.2011.04599.x","article-title":"Review article: remission rates achievable by current therapies for inflammatory bowel disease","volume":"33","author":"Peyrin-Biroulet","year":"2011","journal-title":"Alimentary Pharmacol. and Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","article-title":"Mechanisms of disease: inflammatory bowel diseases","volume":"94","author":"Ramos","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jconrel.2019.11.001","article-title":"Inflammation-triggered local drug release ameliorates colitis by inhibiting dendritic cell migration and Th1\/Th17 differentiation","volume":"316","author":"Regmi","year":"2019","journal-title":"J. Control Release"},{"key":"B42","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1038\/ncomms8449","article-title":"A drug-specific nanocarrier design for efficient anticancer therapy","volume":"6","author":"Shi","year":"2015","journal-title":"Nat. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"734","DOI":"10.17179\/excli2018-1447","article-title":"Unraveling the bioactivity of anticancer peptides as deduced from machine learning","volume":"17","author":"Shoombuatong","year":"2018","journal-title":"EXCLI J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1200\/JCO.2007.13.3165","article-title":"Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma","volume":"26","author":"Sosman","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1002\/jps.20125","article-title":"Pharmacokinetic aspects of biotechnology products","volume":"93","author":"Tang","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1097\/MIB.0b013e318281f362","article-title":"Oral tacrolimus for the treatment of refractory inflammatory bowel disease in the biologic era","volume":"19","author":"Thin","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1038\/s41467-018-06125-0","article-title":"NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease","volume":"9","author":"Tye","year":"2018","journal-title":"Nat. Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.immuni.2009.06.025","article-title":"Intestinal lamina propria dendritic cell subsets have different origin and functions","volume":"31","author":"Varol","year":"2009","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1136\/gutjnl-2014-308323","article-title":"TLR-independent anti-inflammatory function of intestinal epithelial TRAF6 signalling prevents DSS-induced colitis in mice","volume":"65","author":"Vlantis","year":"2016","journal-title":"Gut"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e2202420","DOI":"10.1002\/adhm.202202420","article-title":"Orally administrable aggregation-induced emission-based bionic probe for imaging and ameliorating dextran sulfate sodium-induced inflammatory bowel diseases","volume":"12","author":"Wang","year":"2023","journal-title":"Adv. Healthc. Mater"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat. Protoc."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1039\/c9bm00925f","article-title":"A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine A to alleviate acute severe ulcerative colitis","volume":"7","author":"Wu","year":"","journal-title":"Biomaterials Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.biopha.2018.10.091","article-title":"Tetramethylpyrazine (TMP) ameliorates corneal neovascularization via regulating cell infiltration into cornea after alkali burn","volume":"109","author":"Wu","year":"","journal-title":"Biomed. Pharmacother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1053\/j.gastro.2014.01.056","article-title":"Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice","volume":"146","author":"Xiao","year":"2014","journal-title":"Gastroenterology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ymthe.2016.11.020","article-title":"Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis","volume":"25","author":"Xiao","year":"2017","journal-title":"Mol. Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"12364","DOI":"10.1039\/c8nr01518j","article-title":"Self-assembly of affinity-controlled nanoparticlesviahost\u2013guest interactions for drug delivery","volume":"10","author":"Xue","year":"2018","journal-title":"Nanoscale"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.immuni.2012.08.026","article-title":"Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells","volume":"37","author":"Zigmond","year":"2012","journal-title":"Immunity"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1442876\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T04:36:57Z","timestamp":1723696617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1442876\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":58,"alternative-id":["10.3389\/fphar.2024.1442876"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1442876","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"article-number":"1442876"}}